Viewing Study NCT05563558


Ignite Creation Date: 2025-12-25 @ 12:18 AM
Ignite Modification Date: 2026-01-01 @ 7:23 AM
Study NCT ID: NCT05563558
Status: RECRUITING
Last Update Posted: 2024-06-11
First Post: 2022-09-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS)
Sponsor: Fundacion Oncosur
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module